Here, we found that FBXL6-TKT pathway activity upregulated PD-L1 expression in hepatocytes via the ROS-mTOR axis and then promoted HCC tumorigenesis and lung metastasis. This evidence concerns the gene CD274 and hepatocellular carcinoma.